Detecting anxiety in individuals with Parkinson disease
A systematic review
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To examine diagnostic accuracy of anxiety detection tools compared with a gold standard in outpatient settings among adults with Parkinson disease (PD).
Methods A systematic review was conducted. MEDLINE, EMABASE, PsycINFO, and Cochrane Database of Systematic Reviews were searched to April 7, 2017. Prevalence of anxiety and diagnostic accuracy measures including sensitivity, specificity, and likelihood ratios were gathered. Pooled prevalence of anxiety was calculated using Mantel-Haenszel-weighted DerSimonian and Laird models.
Results A total of 6,300 citations were reviewed with 6 full-text articles included for synthesis. Tools included within this study were the Beck Anxiety Inventory, Geriatric Anxiety Inventory (GAI), Hamilton Anxiety Rating Scale, Hospital Anxiety and Depression Scale–Anxiety, Parkinson's Anxiety Scale (PAS), and Mini–Social Phobia Inventory. Anxiety diagnoses made included generalized anxiety disorder, social phobia, and any anxiety type. Pooled prevalence of anxiety was 30.1% (95% confidence interval 26.1%–34.0%). The GAI had the best-reported sensitivity of 0.86 and specificity of 0.88. The observer-rated PAS had a sensitivity of 0.71 and the highest specificity of 0.91.
Conclusions While there are 6 tools validated for anxiety screening in PD populations, most tools are only validated in single studies. The GAI is brief and easy to use, with a good balance of sensitivity and specificity. The PAS was specifically developed for PD, is brief, and has self-/observer-rated scales, but with lower sensitivity. Health care practitioners involved in PD care need to be aware of available validated tools and choose one that fits their practice.
Glossary
- BAI=
- Beck Anxiety Inventory;
- CI=
- confidence interval;
- DSM=
- Diagnostic and Statistical Manual of Mental Disorders;
- GAD=
- generalized anxiety disorder;
- GAI=
- Geriatric Anxiety Inventory;
- H&Y=
- Hoehn & Yahr scale;
- HADS-A=
- Hospital Anxiety and Depression Scale–Anxiety;
- HARS=
- Hamilton Anxiety Rating Scale;
- ICD=
- International Classification of Diseases;
- LR=
- likelihood ratio;
- M.I.N.I.=
- Mini-International Neuropsychiatric Interview;
- Mini-SPIN=
- Mini Social Phobia Inventory;
- MMSE=
- Mini-Mental State Examination;
- PAS=
- Parkinson's Anxiety Scale;
- PD=
- Parkinson disease;
- SCID-I=
- Structured Clinical Interview
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received July 12, 2017.
- Accepted in final form September 21, 2017.
- Copyright © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Comorbid anxiety, depression, and cognition in MS and other immune-mediated disordersChristiane E. Whitehouse, John D. Fisk, Charles N. Bernstein et al.Neurology, January 11, 2019 -
Articles
Cluster headachesAssociation with anxiety disorders and memory deficitsRicardo E. Jorge, Jorge E. Leston, Stephan Arndt et al.Neurology, August 01, 1999 -
Articles
Changes in depression and anxiety after resective surgery for epilepsyO. Devinsky, W. B. Barr, B. G. Vickrey et al.Neurology, December 12, 2005 -
Articles
Effects of cannabis on cognitive function in patients with multiple sclerosisKimia Honarmand, Mary C. Tierney, Paul O'Connor et al.Neurology, March 28, 2011